Vous êtes sur la page 1sur 2

30954 Federal Register / Vol. 70, No.

103 / Tuesday, May 31, 2005 / Notices

products. We do not intend to make a as amended. The grant applications and Name of Committee: National Center for
final decision on the proposed revision the discussions could disclose Complementary and Alternative Medicine
of CPG 7132b.11 until we complete confidential trade secrets or commercial Special Emphasis Panel Meeting Conflict.
Date: June 24, 2005.
further study of the expiration dating property such as patentable material, Time: 12 p.m. to 5 p.m.
issue to determine the most and personal information concerning Agenda: To review and evaluate grant
scientifically sound approach. We invite individuals associated with the grant applications.
interested persons to submit data applications, the disclosure of which Place: NIH/NCCAM, Democracy II, 6707
establishing appropriate expiration would constitute a clearly unwarranted Democracy Blvd., Suite 401, Bethesda, MD
dating for such drug products. invasion of personal privacy. 20892.
This draft guidance is being issued Contact Person: Jeanette M. Hosseini,
Name of Committee: National Cancer Scientific Review Administrator, National
consistent with FDA’s good guidance Institute Initial Review Group, Subcommittee Center for Complementary and Alternative
practices regulation (21 CFR 10.115). A—Cancer Center. Medicine, 6707 Democracy Blvd, Suite 401,
The draft guidance, when finalized, will Date: August 4–5, 2005. Bethesda, MD 20892, (301) 594–9096.
represent the agency’s current thinking Time: 7 p.m. to 5 p.m.
Agenda: To review and evaluate grant Dated: May 19, 2005.
on expiration dating on nonsterile unit-
dose repackaged drug products. It does applications. LaVerne Y. Stringfield,
not create or confer any rights for or on Place: Marriott Bethesda North Hotel, 5701 Director, Office of Federal Advisory
Marinelli Road, Bethesda, MD 20852. Committee Policy.
any person and does not operate to bind
Contact Person: David E. Maslow, PhD, [FR Doc. 05–10753 Filed 5–27–05; 8:45 am]
FDA or the public. An alternative Scientific Review Administrator, Resources
approach may be used if such approach and Training Review Branch, Division of
BILLING CODE 4140–01–M
satisfies the current requirements of the Extramural Activities, National Cancer
applicable statutes and regulations. Institute, 6116 Executive Blvd., Room 8117,
Bethesda, MD 20892–7405, (301) 496–2330, DEPARTMENT OF HEALTH AND
II. Comments dm65y@nih.gov. HUMAN SERVICES
Interested persons may submit to the (Catalogue of Federal Domestic Assistance
Division of Dockets Management (see National Institutes of Health
Program Nos. 93.392, Cancer Construction;
ADDRESSES) written or electronic 93.393, Cancer Cause and Prevention National Center on Minority Health and
comments on the draft guidance. Submit Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Health Disparities; Notice of Meeting
a single copy of electronic comments or
two paper copies of any mailed Treatment Research; 93.396, Cancer Biology Pursuant to section 10(d) of the
Research; 93.397, Cancer Centers Support; Federal Advisory Committee Act, as
comments, except that individuals may 93.398, Cancer Research Manpower; 93.399,
submit one paper copy. Comments are amended (5 U.S.C. Appendix 2), notice
Cancer Control, National Institutes of Health,
to be identified with the docket number HHS)
is hereby given of a meeting of the
found in brackets in the heading of this National Advisory Council on Minority
Dated: May 19, 2005. Health and Health Disparities.
document. The draft guidance and
received comments may be seen in the LaVerne Y. Stringfield, The meeting will be open to the
Division of Dockets Management Director, Office of Federal Advisory public as indicated below, with
between 9 a.m. and 4 p.m., Monday Committee Policy. attendance limited to space available.
through Friday. [FR Doc. 05–10755 Filed 5–27–05; 8:45 am] Individuals who plan to attend and
BILLING CODE 4140–01–M need special assistance, such as sign
III. Electronic Access language interpretation or other
Persons with access to the Internet reasonable accommodations, should
may obtain the documents at http:// DEPARTMENT OF HEALTH AND notify the Contact Person listed below
www.fda.gov/cder/guidance/index.htm HUMAN SERVICES in advance of the meeting.
or http://ohrms/dockets/default.htm. The meeting will be closed to the
National Institutes of Health public in accordance with the
Dated: May 19, 2005.
provisions set forth in sections
Jeffrey Shuren, National Center for Complementary & 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Assistant Commissioner for Policy. Alternative Medicine; Notice of Closed as amended. The grant applications and
[FR Doc. 05–10702 Filed 5–27–05; 8:45 am] Meeting the discussions could disclose
BILLING CODE 4160–01–S confidential trade secrets or commercial
Pursuant to section 10(d) of the property such as patentable material,
Federal Advisory Committee Act, as and personal information concerning
DEPARTMENT OF HEALTH AND amended (5 U.S.C. Appendix 2), notice individuals associated with the grant
HUMAN SERVICES is hereby given of the following applications, the disclosure of which
meeting. would constitute a clearly unwarranted
National Institutes of Health The meeting will be closed to the invasion of personal privacy.
public in accordance with the Name of Committee: National Advisory
National Cancer Institute; Notice of
provisions set forth in sections Council on Minority Health and Health
Closed Meeting
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Disparities.
Pursuant to section 10(d) of the as amended. The grant applications and Date: June 21, 2005.
Federal Advisory Committee Act, as the discussions could disclose Open: 8:30 a.m. to 4 p.m.
amended (5 U.S.C. Appendix 2), notice confidential trade secrets or commercial Agenda: The agenda will include Opening
is hereby given of the following property such as patentable material, Remarks, Administrative Matters, Director’s
and personal information concerning Report, NCMHD, National Academy of
meeting. Sciences Report on Assessment of NIH
The meeting will be closed to the individuals associated with the grant Minority Research an Training Programs,
public in accordance with the applications, the disclosure of which NIH IC Health Disparities Research Report,
provisions set forth in sections would constitute a clearly unwarranted NCMHD Program Highlights, other business
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., invasion of personal privacy. of the Council.

VerDate jul<14>2003 16:14 May 27, 2005 Jkt 205001 PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 E:\FR\FM\31MYN1.SGM 31MYN1
Federal Register / Vol. 70, No. 103 / Tuesday, May 31, 2005 / Notices 30955

Place: Gaitherburg Marriott Washingtonian the staff of the Institute and discussions Time: 1 p.m. to 5 p.m.
Center, 9751 Washingtonian Boulevard, concerning Institute programs. Agenda: To review and evaluate grant
Gaithersburg, MD 20878. Place: Holiday Inn Georgetown, 2101 applications.
Closed: 4 p.m. to 5 p.m. Wisconsin Avenue, NW., Washington, DC Place: Hyatt Regency Hotel, Inner Harbor,
Agenda: To review and evaluate grant 20007. 300 Light Street, Baltimore, MD 21202.
applications. Closed: 2:30 p.m. to 5 p.m. Contact Person: Patricia A. Haggerty, PhD,
Place: Gaithersburg Marriott Agenda: to review and evaluate grant Section Chief, Clinical Studies and Training
Washingtonian Center, 9751 Washingtonian applications. Scientific Review Group, Review Branch,
Boulevard, Gaithersburg, MD 20878. Place: Holiday Inn Georgetown, 2101 Division of Extramural Affairs, National
Contact Person: Donna Brooks, Asst. Wisconsin Avenue, NW., Washington, DC Heart, Lung, and Blood Institute, NIH, 6701
Director for Administration, National Center 20007. Rockledge Drive, Room 7194, MSC 7924,
on Minority Health and Health Disparities, Contact Person: Lore Anne McNicol, PhD, Bethesda, MD 20892, 301/435–0288,
National Institutes of Health, 6707 Director, Division of Extramural Research, haggert@nhlbi.nih.gov.
Democracy Blvd., Suite 800, Bethesda, MD National Eye Institute, National Institutes of (Catalogue of Federal Domestic Assistance
20892, 301–435–2135, Health, Bethesda, MD 20892, (301) 451–2020. Program Nos. 93.233, National Center for
brooksd@ncmhd.nih.gov. This notice is being published less than 15 Sleep Disorders Research; 93.837, Heart and
Any interested person may file written days prior to the meeting due to the timing Vascular Diseases Research; 93.838, Lung
comments with the committee by forwarding limitations imposed by the review and Diseases Research; 93.839, Blood Diseases
the statement to the Contact Person listed on funding cycle. and Resources Research, National Institutes
this notice. The statement should include the Any interested person may file written of Health, HHS)
name, address, telephone number and when comments with the committee by forwarding
applicable, the business or professional Dated: May 23, 2005.
the statement to the Contact Person listed on
affiliation of the interested person. this notice. The statement should include the LaVerne Y. Stringfield,
Dated: May 19, 2005. name, address, telephone number and when Director, Office of Federal Advisory
applicable, the business or professional Committee Policy.
LaVerne Y. Stringfield,
affiliation of the interested person. [FR Doc. 05–10745 Filed 5–27–05; 8:45 am]
Director, Office of Federal Advisory Information is also available on the
Committee Policy. BILLING CODE 4140–01–M
Institute’s/Center’s home page: http://
[FR Doc. 05–10754 Filed 5–27–05; 8:45 am] www.nei.nih.gov, where an agenda and any
BILLING CODE 4140–01–M additional information for the meeting will
be posted when available.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
(Catalogue of Federal Domestic Assistance
DEPARTMENT OF HEALTH AND Program Nos. 93.867, Vision Research, National Institutes of Health
HUMAN SERVICES National Institutes of Health, HHS)
Dated: May 19, 2005. National Heart, Lung, and Blood
National Institutes of Health Institute; Notice of Closed Meetings
LaVerne Y. Stringfield,
National Eye Institute; Notice of Director, Office of Federal Advisory Pursuant to section 10(d) of the
Meeting Committee Policy. Federal Advisory Committee Act, as
[FR Doc. 05–10756 Filed 5–27–05; 8:45 am] amended (5 U.S.C. Appendix 2), notice
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
BILLING CODE 4140–01–M is hereby given of the following
amended (5 U.S.C. Appendix 2), notice meeting.
is hereby given of a meeting of the The meeting will be closed to the
DEPARTMENT OF HEALTH AND public in accordance with the
National Advisory Eye Council. HUMAN SERVICES
The meeting will be open to the provisions set forth in sections
public as indicated below with 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
National Institutes of Health as amended. The grant applications and
attendance limited to space available.
Individuals who plan to attend and National Heart, Lung and Blood the discussions could disclose
need special assistance, such as sign Institute; Notice of Closed Meeting confidential trade secrets or commercial
language interpretation or other property such as patentable material,
reasonable accommodations, should Pursuant to section 10(d) of the and personal information concerning
notify the Contact Person listed below Federal Advisory Committee Act, as individuals associated with the grant
in advance of the meeting. amended (5 U.S.C. Appendix 2), notice applications, the disclosure of which
The meeting will be closed to the is hereby given of the following would constitute a clearly unwarranted
public in accordance with the meeting. invasion of personal privacy.
provisions set forth in sections The meeting will be closed to the
Name of Committee: National Heart, Lung,
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., public in accordance with the and Blood Institute Special Emphasis Panel
as amended. The grant applications and provisions set forth in section R13 Conference Grants.
the discussions could disclose 552b(c)(6), Title 5 U.S.C., as amended. Date: July 1, 2005.
confidential trade secrets or commercial The grant applications and the Time: 8 a.m. to 5 p.m.
property such as patentable material, discussions could disclose confidential Agenda: To review and evaluate grant
trade secrets or commercial property applications.
and personal information concerning
such as patentable material, and Place: National Institutes of Health,
individuals associated with the grant NHLBI, 6701 Rockledge II, Rockledge Drive,
applications, the disclosure of which personal information concerning
individuals associated with the grant Room 7100, Bethesda, MD 20892, (Telephone
would constitute a clearly unwarranted Conference Call.)
invasion of personal privacy. applications, the disclosure of which Contact Person: Deborah P. Beebe, PhD,
would constitute a clearly unwarranted Director, Division of Extramural Affairs,
Name of Committee: National Advisory invasion of personal privacy.
Eye Council. National Heart, Lung, and Blood Institute,
Date: June 9, 2005. Name of Committee: Heart, Lung, and NIH, 6701 Rockledge Drive, Room 7100,
Open: 8:30 a.m. to 2:30 p.m. Blood Initial Review Group Clinical Trials Bethesda, MD 20892–7924, 301/435–0260.
Agenda: Following opening remarks by the Review Committee. Name of Committee: National Heart, Lung,
Director, NEI, there will be presentations by Date: June 27–28, 2005. and Blood Institute Special Emphasis Panel

VerDate jul<14>2003 16:14 May 27, 2005 Jkt 205001 PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 E:\FR\FM\31MYN1.SGM 31MYN1

Vous aimerez peut-être aussi